FirmLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA files no records under this name; these are its 2 companies' records, each linked to the record.
As of Nov 22, 2026, FDA's public records list Nippon Sanso Holdings and its 2 subsidiaries with 5 510(k) clearances and 5 drug applications. The most recent is a drug application dated Oct 16, 2018: Helium, USP.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Nippon Sanso Holdings and its 2 subsidiaries
A hatched bar is a year that is not over, so its count covers only part of the year.
| Oct 16, 2018 | Helium, USPNDA 212539 | Drug application |
| Jan 9, 2017 | Nitrous Oxide, USPNDA 209989 | Drug application |
| Aug 2, 2013 | Oxygen, USPNDA 205889 | Drug application |
| Aug 2, 2013 | Medical Air, USPNDA 205890 | Drug application |
| Aug 2, 2013 | Nitrogen, NFNDA 205891 | Drug application |
| Aug 3, 1988 | THREE-COMPONENT MEDICAL LASER GAS MIXTURESK882516 · GEX | 510(k) clearance |
| Apr 21, 1987 | O.1 TO 25.0% CARB. DIOX. U.S.P. BALANCE OXYGEN USPK871100 · BXK | 510(k) clearance |
| Apr 20, 1987 | 0.1 TO 25.0% OXYGEN, USP, BALANCE NITROGEN, N.F.K871101 · BXK | 510(k) clearance |
| Apr 20, 1987 | O.1 T0 40.0% CARBON DIOX. O.1 TO 90.0% OXY. U.S.PK871103 · BXK | 510(k) clearance |
| Apr 20, 1987 | O.1 TO 50.0% CARBON DIOXIDE, USP BALANCE NITRO.,NFK871102 · BXK | 510(k) clearance |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.